FRANKLIN, Tenn.--(BUSINESS WIRE)--BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) announced today that Dr. Samuel E. Lynch, president and CEO, will provide an update of corporate activities at the Deutsche Bank 34th Annual Healthcare Conference on Monday, May, 18th at 5:05 p.m. Eastern Time. The presentation is being held in the Hutchinson Ballroom at The InterContinental Boston in Boston, Mass.